APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-opioid Pain Patch

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Non-opioid Pain Patch Industry Growth and Trends Forecast to 2032

20 December 2025117 pages

Choose your research edition.

Industry ResearchNon-opioid Pain Patch Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-opioid Pain Patch Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Non-opioid Pain Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-opioid Pain Patch Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-opioid Pain Patch Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Non-opioid Pain Patch market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Non-opioid Pain Patch is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Non-opioid Pain Patch is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-opioid Pain Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-opioid Pain Patch include Sanofi, Johnson & Johnson, Qizheng, Novartis, Mylan, Lingrui, Huarun 999, GSK and Teikoku Seiyaku, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Non-opioid Pain Patch market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Non-opioid Pain Patch market size, estimates, and forecasts are presented in terms of sales volume (M Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Non-opioid Pain Patch market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Non-opioid Pain Patch.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Non-opioid Pain Patch market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Non-opioid Pain Patch Market by Company

Sanofi

Johnson & Johnson

Qizheng

Novartis

Mylan

Lingrui

Huarun 999

GSK

Teikoku Seiyaku

Nichiban

Mentholatum

Laboratoires Genevrier

Hisamitsu

Haw Par

Endo

BLUE-EMU

Actavis

Non-opioid Pain Patch Segment by Type

Fentanyl Patches

Counter-Irritant Patches

Lidocaine Patches

Diclofenac Patches

Indomethacin Patches

Others

Non-opioid Pain Patch Segment by Application

OTC

Rx

Non-opioid Pain Patch Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-opioid Pain Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-opioid Pain Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-opioid Pain Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-opioid Pain Patch manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Non-opioid Pain Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Fentanyl Patches Table 2. Major Company of Counter-Irritant Patches Table 3. Major Company of Lidocaine Patches Table 4. Major Company of Diclofenac Patches Table 5. Major Company of Indomethacin Patches Table 6. Major Company of Others Table 7. Global Non-opioid Pain Patch Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Non-opioid Pain Patch Sales by Type (2021-2026) & (M Pcs) Table 9. Global Non-opioid Pain Patch Sales Market Share in Volume by Type (2021-2026) Table 10. Global Non-opioid Pain Patch Sales by Type (2021-2026) & (US$ Million) Table 11. Global Non-opioid Pain Patch Sales Market Share in Value by Type (2021-2026) Table 12. Global Non-opioid Pain Patch Price by Type (2021-2026) & (US$/Pcs) Table 13. Global Non-opioid Pain Patch Sales by Type (2027-2032) & (M Pcs) Table 14. Global Non-opioid Pain Patch Sales Market Share in Volume by Type (2027-2032) Table 15. Global Non-opioid Pain Patch Sales by Type (2027-2032) & (US$ Million) Table 16. Global Non-opioid Pain Patch Sales Market Share in Value by Type (2027-2032) Table 17. Global Non-opioid Pain Patch Price by Type (2027-2032) & (US$/Pcs) Table 18. North America Non-opioid Pain Patch Sales by Type (2021-2026) & (M Pcs) Table 19. North America Non-opioid Pain Patch Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Non-opioid Pain Patch Sales by Type (2021-2026) & (M Pcs) Table 21. Europe Non-opioid Pain Patch Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Non-opioid Pain Patch Sales by Type (2021-2026) & (M Pcs) Table 23. Asia-Pacific Non-opioid Pain Patch Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Non-opioid Pain Patch Sales by Type (2021-2026) & (M Pcs) Table 25. Latin America Non-opioid Pain Patch Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Non-opioid Pain Patch Sales by Type (2021-2026) & (M Pcs) Table 27. Middle East and Africa Non-opioid Pain Patch Sales by Type (2021-2026) & (US$ Million) Table 28. Non-opioid Pain Patch Industry Trends Table 29. Non-opioid Pain Patch Industry Drivers Table 30. Non-opioid Pain Patch Industry Opportunities and Challenges Table 31. Non-opioid Pain Patch Industry Restraints Table 32. Global Non-opioid Pain Patch Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Non-opioid Pain Patch Revenue Market Share by Company (2021-2026) Table 34. Global Non-opioid Pain Patch Sales by Company (2021-2026) & (M Pcs) Table 35. Global Non-opioid Pain Patch Sales Share by Company (2021-2026) Table 36. Global Non-opioid Pain Patch Market Price by Company (2021-2026) & (US$/Pcs) Table 37. Global Non-opioid Pain Patch Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Non-opioid Pain Patch Major Company Production Sites and Headquarters Table 39. Global Non-opioid Pain Patch Company, Product Type & Application Table 40. Global Non-opioid Pain Patch Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Non-opioid Pain Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Non-opioid Pain Patch Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Non-opioid Pain Patch Sales by Region (2021-2026) & (M Pcs) Table 45. Global Non-opioid Pain Patch Sales Market Share in Volume by Region (2021-2026) Table 46. Global Non-opioid Pain Patch Sales by Region (2021-2026) & (US$ Million) Table 47. Global Non-opioid Pain Patch Sales Market Share in Value by Region (2021-2026) Table 48. Global Non-opioid Pain Patch Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 49. Global Non-opioid Pain Patch Sales by Region (2027-2032) & (M Pcs) Table 50. Global Non-opioid Pain Patch Sales Market Share in Volume by Region (2027-2032) Table 51. Global Non-opioid Pain Patch Sales by Region (2027-2032) & (US$ Million) Table 52. Global Non-opioid Pain Patch Sales Market Share in Value by Region (2027-2032) Table 53. Global Non-opioid Pain Patch Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2027-2032) Table 54. Global Non-opioid Pain Patch Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Non-opioid Pain Patch Sales by Application (2021-2026) & (M Pcs) Table 56. Global Non-opioid Pain Patch Sales Market Share in Volume by Application (2021-2026) Table 57. Global Non-opioid Pain Patch Sales by Application (2021-2026) & (US$ Million) Table 58. Global Non-opioid Pain Patch Sales Market Share in Value by Application (2021-2026) Table 59. Global Non-opioid Pain Patch Price by Application (2021-2026) & (US$/Pcs) Table 60. Global Non-opioid Pain Patch Sales by Application (2027-2032) & (M Pcs) Table 61. Global Non-opioid Pain Patch Sales Market Share in Volume by Application (2027-2032) Table 62. Global Non-opioid Pain Patch Sales by Application (2027-2032) & (US$ Million) Table 63. Global Non-opioid Pain Patch Sales Market Share in Value by Application (2027-2032) Table 64. Global Non-opioid Pain Patch Price by Application (2027-2032) & (US$/Pcs) Table 65. North America Non-opioid Pain Patch Sales by Application (2021-2026) & (M Pcs) Table 66. North America Non-opioid Pain Patch Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Non-opioid Pain Patch Sales by Application (2021-2026) & (M Pcs) Table 68. Europe Non-opioid Pain Patch Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Non-opioid Pain Patch Sales by Application (2021-2026) & (M Pcs) Table 70. Asia-Pacific Non-opioid Pain Patch Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Non-opioid Pain Patch Sales by Application (2021-2026) & (M Pcs) Table 72. Latin America Non-opioid Pain Patch Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Non-opioid Pain Patch Sales by Application (2021-2026) & (M Pcs) Table 74. Middle East and Africa Non-opioid Pain Patch Sales by Application (2021-2026) & (US$ Million) Table 75. Sanofi Company Information Table 76. Sanofi Business Overview Table 77. Sanofi Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 78. Sanofi Non-opioid Pain Patch Product Portfolio Table 79. Sanofi Recent Development Table 80. Johnson & Johnson Company Information Table 81. Johnson & Johnson Business Overview Table 82. Johnson & Johnson Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 83. Johnson & Johnson Non-opioid Pain Patch Product Portfolio Table 84. Johnson & Johnson Recent Development Table 85. Qizheng Company Information Table 86. Qizheng Business Overview Table 87. Qizheng Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 88. Qizheng Non-opioid Pain Patch Product Portfolio Table 89. Qizheng Recent Development Table 90. Novartis Company Information Table 91. Novartis Business Overview Table 92. Novartis Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 93. Novartis Non-opioid Pain Patch Product Portfolio Table 94. Novartis Recent Development Table 95. Mylan Company Information Table 96. Mylan Business Overview Table 97. Mylan Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 98. Mylan Non-opioid Pain Patch Product Portfolio Table 99. Mylan Recent Development Table 100. Lingrui Company Information Table 101. Lingrui Business Overview Table 102. Lingrui Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 103. Lingrui Non-opioid Pain Patch Product Portfolio Table 104. Lingrui Recent Development Table 105. Huarun 999 Company Information Table 106. Huarun 999 Business Overview Table 107. Huarun 999 Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 108. Huarun 999 Non-opioid Pain Patch Product Portfolio Table 109. Huarun 999 Recent Development Table 110. GSK Company Information Table 111. GSK Business Overview Table 112. GSK Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 113. GSK Non-opioid Pain Patch Product Portfolio Table 114. GSK Recent Development Table 115. Teikoku Seiyaku Company Information Table 116. Teikoku Seiyaku Business Overview Table 117. Teikoku Seiyaku Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 118. Teikoku Seiyaku Non-opioid Pain Patch Product Portfolio Table 119. Teikoku Seiyaku Recent Development Table 120. Nichiban Company Information Table 121. Nichiban Business Overview Table 122. Nichiban Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 123. Nichiban Non-opioid Pain Patch Product Portfolio Table 124. Nichiban Recent Development Table 125. Mentholatum Company Information Table 126. Mentholatum Business Overview Table 127. Mentholatum Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 128. Mentholatum Non-opioid Pain Patch Product Portfolio Table 129. Mentholatum Recent Development Table 130. Laboratoires Genevrier Company Information Table 131. Laboratoires Genevrier Business Overview Table 132. Laboratoires Genevrier Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 133. Laboratoires Genevrier Non-opioid Pain Patch Product Portfolio Table 134. Laboratoires Genevrier Recent Development Table 135. Hisamitsu Company Information Table 136. Hisamitsu Business Overview Table 137. Hisamitsu Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 138. Hisamitsu Non-opioid Pain Patch Product Portfolio Table 139. Hisamitsu Recent Development Table 140. Haw Par Company Information Table 141. Haw Par Business Overview Table 142. Haw Par Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 143. Haw Par Non-opioid Pain Patch Product Portfolio Table 144. Haw Par Recent Development Table 145. Endo Company Information Table 146. Endo Business Overview Table 147. Endo Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 148. Endo Non-opioid Pain Patch Product Portfolio Table 149. Endo Recent Development Table 150. BLUE-EMU Company Information Table 151. BLUE-EMU Business Overview Table 152. BLUE-EMU Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 153. BLUE-EMU Non-opioid Pain Patch Product Portfolio Table 154. BLUE-EMU Recent Development Table 155. Actavis Company Information Table 156. Actavis Business Overview Table 157. Actavis Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 158. Actavis Non-opioid Pain Patch Product Portfolio Table 159. Actavis Recent Development Table 160. North America Non-opioid Pain Patch Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 161. North America Non-opioid Pain Patch Sales by Country (2021-2026) & (M Pcs) Table 162. North America Non-opioid Pain Patch Sales Market Share by Country (2021-2026) Table 163. North America Non-opioid Pain Patch Sales Forecast by Country (2027-2032) & (M Pcs) Table 164. North America Non-opioid Pain Patch Sales Market Share Forecast by Country (2027-2032) Table 165. North America Non-opioid Pain Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 166. North America Non-opioid Pain Patch Market Size by Country (2021-2026) & (US$ Million) Table 167. North America Non-opioid Pain Patch Market Share by Country (2021-2026) Table 168. North America Non-opioid Pain Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 169. North America Non-opioid Pain Patch Market Share Forecast by Country (2027-2032) Table 170. Europe Non-opioid Pain Patch Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 171. Europe Non-opioid Pain Patch Sales by Country (2021-2026) & (M Pcs) Table 172. Europe Non-opioid Pain Patch Sales Market Share by Country (2021-2026) Table 173. Europe Non-opioid Pain Patch Sales Forecast by Country (2027-2032) & (M Pcs) Table 174. Europe Non-opioid Pain Patch Sales Market Share Forecast by Country (2027-2032) Table 175. Europe Non-opioid Pain Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 176. Europe Non-opioid Pain Patch Market Size by Country (2021-2026) & (US$ Million) Table 177. Europe Non-opioid Pain Patch Market Share by Country (2021-2026) Table 178. Europe Non-opioid Pain Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 179. Europe Non-opioid Pain Patch Market Share Forecast by Country (2027-2032) Table 180. Asia-Pacific Non-opioid Pain Patch Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 181. Asia-Pacific Non-opioid Pain Patch Sales by Country (2021-2026) & (M Pcs) Table 182. Asia-Pacific Non-opioid Pain Patch Sales Market Share by Country (2021-2026) Table 183. Asia-Pacific Non-opioid Pain Patch Sales Forecast by Country (2027-2032) & (M Pcs) Table 184. Asia-Pacific Non-opioid Pain Patch Sales Market Share Forecast by Country (2027-2032) Table 185. Asia-Pacific Non-opioid Pain Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 186. Asia-Pacific Non-opioid Pain Patch Market Size by Country (2021-2026) & (US$ Million) Table 187. Asia-Pacific Non-opioid Pain Patch Market Share by Country (2021-2026) Table 188. Asia-Pacific Non-opioid Pain Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 189. Asia-Pacific Non-opioid Pain Patch Market Share Forecast by Country (2027-2032) Table 190. Latin America Non-opioid Pain Patch Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 191. Latin America Non-opioid Pain Patch Sales by Country (2021-2026) & (M Pcs) Table 192. Latin America Non-opioid Pain Patch Sales Market Share by Country (2021-2026) Table 193. Latin America Non-opioid Pain Patch Sales Forecast by Country (2027-2032) & (M Pcs) Table 194. Latin America Non-opioid Pain Patch Sales Market Share Forecast by Country (2027-2032) Table 195. Latin America Non-opioid Pain Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 196. Latin America Non-opioid Pain Patch Market Size by Country (2021-2026) & (US$ Million) Table 197. Latin America Non-opioid Pain Patch Market Share by Country (2021-2026) Table 198. Latin America Non-opioid Pain Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 199. Latin America Non-opioid Pain Patch Market Share Forecast by Country (2027-2032) Table 200. Middle East and Africa Non-opioid Pain Patch Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 201. Middle East and Africa Non-opioid Pain Patch Sales by Country (2021-2026) & (M Pcs) Table 202. Middle East and Africa Non-opioid Pain Patch Sales Market Share by Country (2021-2026) Table 203. Middle East and Africa Non-opioid Pain Patch Sales Forecast by Country (2027-2032) & (M Pcs) Table 204. Middle East and Africa Non-opioid Pain Patch Sales Market Share Forecast by Country (2027-2032) Table 205. Middle East and Africa Non-opioid Pain Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 206. Middle East and Africa Non-opioid Pain Patch Market Size by Country (2021-2026) & (US$ Million) Table 207. Middle East and Africa Non-opioid Pain Patch Market Share by Country (2021-2026) Table 208. Middle East and Africa Non-opioid Pain Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 209. Middle East and Africa Non-opioid Pain Patch Market Share Forecast by Country (2027-2032) Table 210. Key Raw Materials Table 211. Raw Materials Key Suppliers Table 212. Non-opioid Pain Patch Distributors List Table 213. Non-opioid Pain Patch Customers List Table 214. Research Programs/Design for This Report Table 215. Authors List of This Report Table 216. Secondary Sources Table 217. Primary Sources List of Figures Figure 1. Non-opioid Pain Patch Image Figure 2. Global Non-opioid Pain Patch Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-opioid Pain Patch Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-opioid Pain Patch Sales (2021-2032) & (M Pcs) Figure 5. Fentanyl Patches Image Figure 6. Global Fentanyl Patches Sales YoY Growth (2021-2032) & (M Pcs) Figure 7. Counter-Irritant Patches Image Figure 8. Global Counter-Irritant Patches Sales YoY Growth (2021-2032) & (M Pcs) Figure 9. Lidocaine Patches Image Figure 10. Global Lidocaine Patches Sales YoY Growth (2021-2032) & (M Pcs) Figure 11. Diclofenac Patches Image Figure 12. Global Diclofenac Patches Sales YoY Growth (2021-2032) & (M Pcs) Figure 13. Indomethacin Patches Image Figure 14. Global Indomethacin Patches Sales YoY Growth (2021-2032) & (M Pcs) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (M Pcs) Figure 17. Global Non-opioid Pain Patch Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Non-opioid Pain Patch Market Share by Type 2025 VS 2032 Figure 19. North America Non-opioid Pain Patch Sales Market Share in Volume by Type in 2025 Figure 20. North America Non-opioid Pain Patch Sales Market Share in Value by Type in 2025 Figure 21. Europe Non-opioid Pain Patch Sales Market Share in Volume by Type in 2025 Figure 22. Europe Non-opioid Pain Patch Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Non-opioid Pain Patch Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Non-opioid Pain Patch Sales Market Share in Value by Type in 2025 Figure 25. Latin America Non-opioid Pain Patch Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Non-opioid Pain Patch Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Non-opioid Pain Patch Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Non-opioid Pain Patch Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Non-opioid Pain Patch Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. OTC Image Figure 32. Global OTC Sales YoY Growth (2021-2032) & (M Pcs) Figure 33. Rx Image Figure 34. Global Rx Sales YoY Growth (2021-2032) & (M Pcs) Figure 35. Global Non-opioid Pain Patch Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Non-opioid Pain Patch Market Share by Application 2025 VS 2032 Figure 37. North America Non-opioid Pain Patch Sales Market Share in Volume by Application in 2025 Figure 38. North America Non-opioid Pain Patch Sales Market Share in Value by Application in 2025 Figure 39. Europe Non-opioid Pain Patch Sales Market Share in Volume by Application in 2025 Figure 40. Europe Non-opioid Pain Patch Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Non-opioid Pain Patch Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Non-opioid Pain Patch Sales Market Share in Value by Application in 2025 Figure 43. Latin America Non-opioid Pain Patch Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Non-opioid Pain Patch Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Non-opioid Pain Patch Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Non-opioid Pain Patch Sales Market Share in Value by Application in 2025 Figure 47. North America Non-opioid Pain Patch Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 48. North America Non-opioid Pain Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Non-opioid Pain Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Non-opioid Pain Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Non-opioid Pain Patch Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 52. Europe Non-opioid Pain Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Non-opioid Pain Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Non-opioid Pain Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Non-opioid Pain Patch Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 56. Asia-Pacific Non-opioid Pain Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Non-opioid Pain Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Non-opioid Pain Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Non-opioid Pain Patch Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 60. Latin America Non-opioid Pain Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Non-opioid Pain Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Non-opioid Pain Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Non-opioid Pain Patch Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 64. Middle East and Africa Non-opioid Pain Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Non-opioid Pain Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Non-opioid Pain Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Non-opioid Pain Patch Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Non-opioid Pain Patch Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Fentanyl Patches
  • Counter-Irritant Patches
  • Lidocaine Patches
  • Diclofenac Patches
  • Indomethacin Patches
  • Others
Applications
  • OTC
  • Rx
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Qizheng
  • Novartis
  • Mylan
  • Lingrui
  • Huarun 999
  • GSK
  • Teikoku Seiyaku
  • Nichiban
  • Mentholatum
  • Laboratoires Genevrier
  • Hisamitsu
  • Haw Par
  • Endo
  • BLUE-EMU
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non-opioid Pain Patch Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Non-opioid Pain Patch Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Non-opioid Pain Patch Market by Type
  6. 1.3.1 Fentanyl Patches
  7. 1.3.2 Counter-Irritant Patches
  8. 1.3.3 Lidocaine Patches
  9. 1.3.4 Diclofenac Patches
  10. 1.3.5 Indomethacin Patches
  11. 1.3.6 Others
  12. 1.4 Global Non-opioid Pain Patch Market Size by Type
  13. 1.4.1 Global Non-opioid Pain Patch Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Non-opioid Pain Patch Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Non-opioid Pain Patch Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Non-opioid Pain Patch Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Non-opioid Pain Patch Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Non-opioid Pain Patch Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Non-opioid Pain Patch Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Non-opioid Pain Patch Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Non-opioid Pain Patch Industry Trends
  2. 2.2 Non-opioid Pain Patch Industry Drivers
  3. 2.3 Non-opioid Pain Patch Industry Opportunities and Challenges
  4. 2.4 Non-opioid Pain Patch Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Non-opioid Pain Patch Revenue (2021-2026)
  2. 3.2 Global Top Players by Non-opioid Pain Patch Sales (2021-2026)
  3. 3.3 Global Top Players by Non-opioid Pain Patch Price (2021-2026)
  4. 3.4 Global Non-opioid Pain Patch Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non-opioid Pain Patch Major Company Production Sites & Headquarters
  6. 3.6 Global Non-opioid Pain Patch Company, Product Type & Application
  7. 3.7 Global Non-opioid Pain Patch Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non-opioid Pain Patch Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non-opioid Pain Patch Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non-opioid Pain Patch Tier 1, Tier 2, and Tier 3
4 Non-opioid Pain Patch Regional Status and Outlook
  1. 4.1 Global Non-opioid Pain Patch Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Non-opioid Pain Patch Historic Market Size by Region
  3. 4.2.1 Global Non-opioid Pain Patch Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Non-opioid Pain Patch Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Non-opioid Pain Patch Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Non-opioid Pain Patch Forecasted Market Size by Region
  7. 4.3.1 Global Non-opioid Pain Patch Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Non-opioid Pain Patch Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Non-opioid Pain Patch Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Non-opioid Pain Patch by Application
  1. 5.1 Non-opioid Pain Patch Market by Application
  2. 5.1.1 OTC
  3. 5.1.2 Rx
  4. 5.2 Global Non-opioid Pain Patch Market Size by Application
  5. 5.2.1 Global Non-opioid Pain Patch Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Non-opioid Pain Patch Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Non-opioid Pain Patch Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Non-opioid Pain Patch Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Non-opioid Pain Patch Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Non-opioid Pain Patch Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Non-opioid Pain Patch Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Non-opioid Pain Patch Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Non-opioid Pain Patch Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Non-opioid Pain Patch Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Qizheng
  14. 6.3.1 Qizheng Company Information
  15. 6.3.2 Qizheng Business Overview
  16. 6.3.3 Qizheng Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Qizheng Non-opioid Pain Patch Product Portfolio
  18. 6.3.5 Qizheng Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Non-opioid Pain Patch Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Mylan
  26. 6.5.1 Mylan Company Information
  27. 6.5.2 Mylan Business Overview
  28. 6.5.3 Mylan Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mylan Non-opioid Pain Patch Product Portfolio
  30. 6.5.5 Mylan Recent Developments
  31. 6.6 Lingrui
  32. 6.6.1 Lingrui Company Information
  33. 6.6.2 Lingrui Business Overview
  34. 6.6.3 Lingrui Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Lingrui Non-opioid Pain Patch Product Portfolio
  36. 6.6.5 Lingrui Recent Developments
  37. 6.7 Huarun 999
  38. 6.7.1 Huarun 999 Company Information
  39. 6.7.2 Huarun 999 Business Overview
  40. 6.7.3 Huarun 999 Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Huarun 999 Non-opioid Pain Patch Product Portfolio
  42. 6.7.5 Huarun 999 Recent Developments
  43. 6.8 GSK
  44. 6.8.1 GSK Company Information
  45. 6.8.2 GSK Business Overview
  46. 6.8.3 GSK Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GSK Non-opioid Pain Patch Product Portfolio
  48. 6.8.5 GSK Recent Developments
  49. 6.9 Teikoku Seiyaku
  50. 6.9.1 Teikoku Seiyaku Company Information
  51. 6.9.2 Teikoku Seiyaku Business Overview
  52. 6.9.3 Teikoku Seiyaku Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Teikoku Seiyaku Non-opioid Pain Patch Product Portfolio
  54. 6.9.5 Teikoku Seiyaku Recent Developments
  55. 6.10 Nichiban
  56. 6.10.1 Nichiban Company Information
  57. 6.10.2 Nichiban Business Overview
  58. 6.10.3 Nichiban Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Nichiban Non-opioid Pain Patch Product Portfolio
  60. 6.10.5 Nichiban Recent Developments
  61. 6.11 Mentholatum
  62. 6.11.1 Mentholatum Company Information
  63. 6.11.2 Mentholatum Business Overview
  64. 6.11.3 Mentholatum Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Mentholatum Non-opioid Pain Patch Product Portfolio
  66. 6.11.5 Mentholatum Recent Developments
  67. 6.12 Laboratoires Genevrier
  68. 6.12.1 Laboratoires Genevrier Company Information
  69. 6.12.2 Laboratoires Genevrier Business Overview
  70. 6.12.3 Laboratoires Genevrier Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Laboratoires Genevrier Non-opioid Pain Patch Product Portfolio
  72. 6.12.5 Laboratoires Genevrier Recent Developments
  73. 6.13 Hisamitsu
  74. 6.13.1 Hisamitsu Company Information
  75. 6.13.2 Hisamitsu Business Overview
  76. 6.13.3 Hisamitsu Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hisamitsu Non-opioid Pain Patch Product Portfolio
  78. 6.13.5 Hisamitsu Recent Developments
  79. 6.14 Haw Par
  80. 6.14.1 Haw Par Company Information
  81. 6.14.2 Haw Par Business Overview
  82. 6.14.3 Haw Par Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Haw Par Non-opioid Pain Patch Product Portfolio
  84. 6.14.5 Haw Par Recent Developments
  85. 6.15 Endo
  86. 6.15.1 Endo Company Information
  87. 6.15.2 Endo Business Overview
  88. 6.15.3 Endo Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Endo Non-opioid Pain Patch Product Portfolio
  90. 6.15.5 Endo Recent Developments
  91. 6.16 BLUE-EMU
  92. 6.16.1 BLUE-EMU Company Information
  93. 6.16.2 BLUE-EMU Business Overview
  94. 6.16.3 BLUE-EMU Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 BLUE-EMU Non-opioid Pain Patch Product Portfolio
  96. 6.16.5 BLUE-EMU Recent Developments
  97. 6.17 Actavis
  98. 6.17.1 Actavis Company Information
  99. 6.17.2 Actavis Business Overview
  100. 6.17.3 Actavis Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Actavis Non-opioid Pain Patch Product Portfolio
  102. 6.17.5 Actavis Recent Developments
7 North America by Country
  1. 7.1 North America Non-opioid Pain Patch Sales by Country
  2. 7.1.1 North America Non-opioid Pain Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Non-opioid Pain Patch Sales by Country (2021-2026)
  4. 7.1.3 North America Non-opioid Pain Patch Sales Forecast by Country (2027-2032)
  5. 7.2 North America Non-opioid Pain Patch Market Size by Country
  6. 7.2.1 North America Non-opioid Pain Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Non-opioid Pain Patch Market Size by Country (2021-2026)
  8. 7.2.3 North America Non-opioid Pain Patch Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Non-opioid Pain Patch Sales by Country
  2. 8.1.1 Europe Non-opioid Pain Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Non-opioid Pain Patch Sales by Country (2021-2026)
  4. 8.1.3 Europe Non-opioid Pain Patch Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Non-opioid Pain Patch Market Size by Country
  6. 8.2.1 Europe Non-opioid Pain Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Non-opioid Pain Patch Market Size by Country (2021-2026)
  8. 8.2.3 Europe Non-opioid Pain Patch Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Non-opioid Pain Patch Sales by Country
  2. 9.1.1 Asia-Pacific Non-opioid Pain Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Non-opioid Pain Patch Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Non-opioid Pain Patch Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Non-opioid Pain Patch Market Size by Country
  6. 9.2.1 Asia-Pacific Non-opioid Pain Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Non-opioid Pain Patch Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Non-opioid Pain Patch Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Non-opioid Pain Patch Sales by Country
  2. 10.1.1 South America Non-opioid Pain Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Non-opioid Pain Patch Sales by Country (2021-2026)
  4. 10.1.3 South America Non-opioid Pain Patch Sales Forecast by Country (2027-2032)
  5. 10.2 South America Non-opioid Pain Patch Market Size by Country
  6. 10.2.1 South America Non-opioid Pain Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Non-opioid Pain Patch Market Size by Country (2021-2026)
  8. 10.2.3 South America Non-opioid Pain Patch Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Non-opioid Pain Patch Sales by Country
  2. 11.1.1 Middle East and Africa Non-opioid Pain Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Non-opioid Pain Patch Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Non-opioid Pain Patch Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Non-opioid Pain Patch Market Size by Country
  6. 11.2.1 Middle East and Africa Non-opioid Pain Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Non-opioid Pain Patch Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Non-opioid Pain Patch Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Non-opioid Pain Patch Value Chain Analysis
  2. 12.1.1 Non-opioid Pain Patch Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Non-opioid Pain Patch Production Mode & Process
  7. 12.2 Non-opioid Pain Patch Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Non-opioid Pain Patch Distributors
  10. 12.2.3 Non-opioid Pain Patch Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst